一本关于在资源有限地区治疗牛皮的生物治疗方法的实用指南
Leena Chularojanamontri1, Padcha Pongcharoen2, Ploysyne Rattanakaemakorn3
1Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Asian Pacific journal of allergy and immunology
|November 3, 2025
概括
生物疗法为中度至重度的牛皮提供有效,安全的治疗方法,改善生活质量. 审查涵盖了各种生物药物的有效性,安全性和现实世界的使用,用于治疗牛皮.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对特定炎症途径的生物疗法彻底改变了牛皮的治疗方法.
- 生物制剂,特别是第二代药物,比传统治疗中度至重度牛皮的疗法提供了更好的疗效和安全性.
- 这些先进的治疗方法可以显著提高患者的生活质量.
研究的目的:
- 审查牛皮的生物药物的疗效,安全性和实际应用.
- 突出生物制剂在难以治疗的地区的有效性.
- 讨论影响治疗反应的因素和优化治疗结果的策略.
主要方法:
- 目前关于牛皮的生物疗法的文献综述.
- 对各种生物类的疗效和安全数据的分析,包括TNF-alpha,IL-12/23,IL-17和IL-23抑制剂.
- 对药物持续性,免疫性和治疗转换的真实数据的检查.
主要成果:
- 生物药物在中度至重度的牛皮中表现出显著的疗效,包括难以治疗的区域,如头皮,指甲和棕植物区域.
- 不同的生物药物表现出免疫性,结合性亲和性和半衰期的变化,影响治疗反应和药物存活率.
- 类内和类间的生物切换是管理不充分反应或不良影响的有效策略.
结论:
- 生物疗法耐受性良好,在牛皮管理中具有有利的长期安全性.
- 考虑并发症和先前病史的个性化治疗选择对于优化患者的治疗结果和扩大生物选择至关重要.
- 在现实世界中,药物存活率和患者特异性因素对于最大限度地发挥生物制剂在牛皮治疗中的益处至关重要.
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
476
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
476
01:29Inflammatory Bowel Disease IV: Pharmacological Management
463
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
463
01:24Treatment Strategies for Psychological Disorders
687
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
687
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
144
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
144
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
140
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
140
01:29Therapeutic Drug Monitoring: Affecting Factors
193
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
193